NAMPT and Insulin resistance: We first examined the effects of a specific inhibitor of JAK2/STAT3, AG490, and a specific NF-κB inhibitor, BAY11-7082, on the visfatin-induced expression of inflammatory cytokines and insulin resistance in HepG2 cells.